PubRank

Allison Naleway

Author PubWeight™ 33.52‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Effect of age on the risk of Fever and seizures following immunization with measles-containing vaccines in children. JAMA Pediatr 2013 2.86
2 Measles-mumps-rubella-varicella combination vaccine and the risk of febrile seizures. Pediatrics 2010 2.39
3 Monitoring the safety of quadrivalent human papillomavirus vaccine: findings from the Vaccine Safety Datalink. Vaccine 2011 1.70
4 The Vaccine Safety Datalink: a model for monitoring immunization safety. Pediatrics 2011 1.60
5 Risk of intussusception after monovalent rotavirus vaccination. N Engl J Med 2014 1.59
6 Safety of the yellow Fever vaccine: a retrospective study. J Travel Med 2013 1.38
7 Maternal safety of trivalent inactivated influenza vaccine in pregnant women. Obstet Gynecol 2013 1.24
8 Active surveillance for adverse events: the experience of the Vaccine Safety Datalink project. Pediatrics 2011 1.20
9 H1N1 and seasonal influenza vaccine safety in the vaccine safety datalink project. Am J Prev Med 2011 1.12
10 Inactivated influenza vaccine during pregnancy and risks for adverse obstetric events. Obstet Gynecol 2013 1.07
11 Predictors of seasonal influenza vaccination during pregnancy. Obstet Gynecol 2013 1.04
12 Detecting possible vaccine adverse events in clinical notes of the electronic medical record. Vaccine 2009 1.04
13 Measles-containing vaccines and febrile seizures in children age 4 to 6 years. Pediatrics 2012 0.96
14 Detecting possible vaccination reactions in clinical notes. AMIA Annu Symp Proc 2005 0.96
15 The expected emotional benefits of influenza vaccination strongly affect pre-season intentions and subsequent vaccination among healthcare personnel. Vaccine 2012 0.96
16 Further evidence for bias in observational studies of influenza vaccine effectiveness: the 2009 influenza A(H1N1) pandemic. Am J Epidemiol 2013 0.93
17 Factors predicting completion of the human papillomavirus vaccine series. J Adolesc Health 2012 0.87
18 Postlicensure surveillance for pre-specified adverse events following the 13-valent pneumococcal conjugate vaccine in children. Vaccine 2013 0.86
19 Trends in influenza vaccine coverage in pregnant women, 2008 to 2012. Perm J 2013 0.85
20 Absence of associations between influenza vaccines and increased risks of seizures, Guillain-Barré syndrome, encephalitis, or anaphylaxis in the 2012-2013 season. Pharmacoepidemiol Drug Saf 2014 0.84
21 The Pregnancy and Influenza Project: design of an observational case-cohort study to evaluate influenza burden and vaccine effectiveness among pregnant women and their infants. Am J Obstet Gynecol 2011 0.84
22 Antibody response to influenza A(H1N1)pdm09 among healthcare personnel receiving trivalent inactivated vaccine: effect of prior monovalent inactivated vaccine. J Infect Dis 2013 0.83
23 Incidence of neonatal herpes simplex virus infections in two managed care organizations: implications for surveillance. Sex Transm Dis 2008 0.83
24 Consistency of influenza A virus detection test results across respiratory specimen collection methods using real-time reverse transcription-PCR. J Clin Microbiol 2013 0.82
25 Mortality rates and cause-of-death patterns in a vaccinated population. Am J Prev Med 2013 0.82
26 Frequency of medically attended adverse events following tetanus and diphtheria toxoid vaccine in adolescents and young adults: a Vaccine Safety Datalink study. BMC Infect Dis 2009 0.82
27 Assessing the safety of influenza immunization during pregnancy: the Vaccine Safety Datalink. Am J Obstet Gynecol 2012 0.80
28 Safety of a tetanus-diphtheria-acellular pertussis vaccine when used off-label in an elderly population. Clin Infect Dis 2012 0.79
29 Risk of medically attended local reactions following diphtheria toxoid containing vaccines in adolescents and young adults: a Vaccine Safety Datalink study. Vaccine 2009 0.78
30 Monitoring vaccine safety using the Vaccine Safety Datalink: utilizing immunization registries for pandemic influenza. Vaccine 2011 0.77
31 Validation of a screening instrument to identify persons for exclusion from smallpox vaccination. Clin Infect Dis 2005 0.75